About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Business of Biosimilars & Biobetters Conference | Main | Conference & CLE Calendar »

July 15, 2011

Comments

"Patent Docs author Dr. Kevin E. Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; and Jacqueline D. Wright Bonilla of Foley & Lardner LLP, will discuss whether "products of nature" (e.g., genetic material) constitute patentable subject matter, "

And he's going to say N O. Right? Right?

Seriously though, when is the Myriad decision probably going to come out?

I actually think this webinar would be an interesting one to attend. With how many new advances we are having with DNA I have a feeling there is some debate as to whether "products of nature" are patentable. I have my own opinions, but I would like to see what others have to say about it and the actual legal decision on it.

The comments to this entry are closed.

March 2025

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31